Literature DB >> 29781568

Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia.

Tarek Alsaied1,2, Omar Niss3, Adam W Powell1, Robert J Fleck4, James F Cnota1, Clifford Chin1, Punam Malik3,5, Charles T Quinn3, Michael D Taylor1.   

Abstract

BACKGROUND: Left ventricular diastolic dysfunction (DD) is an independent risk factor for mortality in sickle cell anemia (SCA) and is associated with increased extracellular volume (ECV) on cardiac MRI (CMR). Exercise impairment is common in SCA, but its causes and prognostic value are not well understood.
OBJECTIVE: To study the effects of DD and ECV on cardiopulmonary exercise test (CPET) in patients with SCA. METHODS AND
RESULTS: As part of a prospective study to characterize the cardiomyopathy of SCA (NCT02410811), 20 children and adults with SCA underwent CMR, echocardiography, and cycle ergometer CPET (age range 8-43 years). Maximum exercise was reached in 18 patients and 17 (94%) had reduced exercise capacity (%predicted VO2 less than 80%). Six patients had DD and none had systolic dysfunction. Patients with DD had lower exercise capacity compared to patients with normal diastolic function (%predicted VO2 48.2 ± 9.1% vs. 61.2 ± 11.7%; P = 0.01). The z-score of left ventricular lateral E/e' ratio, which is a marker of DD, was negatively associated with %predicted VO2 (r = -0.61, P = 0.01). All patients with moderate-to-severe exercise impairment (%predicted VO2  < 60%) had lateral E/e' z-score > 2. In a multivariate analysis, lateral E/e' z-score was independently associated with %predicted VO2 (P = 0.02). All participants had elevated ECV but the degree of elevation was not associated with exercise parameters.
CONCLUSION: Left ventricular DD is associated with decreased exercise capacity in SCA. Interventions to prevent or delay DD could improve exercise capacity, quality of life, and long-term outcomes in SCA.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  diastolic dysfunction; exercise echocardiogram; exercise impairment; left atrial pressure; myocardial fibrosis; sickle cell anemia

Mesh:

Year:  2018        PMID: 29781568      PMCID: PMC6019177          DOI: 10.1002/pbc.27113

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  47 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children.

Authors:  Benjamin W Eidem; Colin J McMahon; Radha R Cohen; Jin Wu; Irina Finkelshteyn; John P Kovalchin; Nancy A Ayres; Louis I Bezold; E O'Brian Smith; Ricardo H Pignatelli
Journal:  J Am Soc Echocardiogr       Date:  2004-03       Impact factor: 5.251

3.  Differences of lateral and septal mitral annulus velocity by tissue Doppler imaging in the evaluation of left ventricular diastolic function.

Authors:  Hyeun S Park; Sanjay D Naik; Wilbert S Aronow; Paul F Visintainer; Manisha Das; John A McClung; Robert N Belkin
Journal:  Am J Cardiol       Date:  2006-08-18       Impact factor: 2.778

4.  Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure.

Authors:  Marco Guazzi; Lawrence P Cahalin; Ross Arena
Journal:  J Card Fail       Date:  2013-07       Impact factor: 5.712

Review 5.  A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure.

Authors:  Lawrence P Cahalin; Paul Chase; Ross Arena; Jonathan Myers; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman; Sherry Pinkstaff; Carl J Lavie; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

6.  Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.

Authors:  Vandana Sachdev; Gregory J Kato; J Simon R Gibbs; Robyn J Barst; Roberto F Machado; Mehdi Nouraie; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico M Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; James G Taylor; Hwaida Hannoush; Jonathan C Goldsmith; Mark T Gladwin; Victor R Gordeuk
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

7.  Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Thomas P Olson; Vojtech Melenovsky; Barry A Borlaug
Journal:  Circulation       Date:  2016-12-30       Impact factor: 29.690

8.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

9.  Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study.

Authors:  Mario Kasner; Dirk Westermann; Paul Steendijk; Regina Gaub; Ursula Wilkenshoff; Kerstin Weitmann; Wolfgang Hoffmann; Wolfgang Poller; Heinz-Peter Schultheiss; Matthias Pauschinger; Carsten Tschöpe
Journal:  Circulation       Date:  2007-07-23       Impact factor: 29.690

Review 10.  Normal values for cardiovascular magnetic resonance in adults and children.

Authors:  Nadine Kawel-Boehm; Alicia Maceira; Emanuela R Valsangiacomo-Buechel; Jens Vogel-Claussen; Evrim B Turkbey; Rupert Williams; Sven Plein; Michael Tee; John Eng; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2015-04-18       Impact factor: 5.364

View more
  6 in total

1.  Abnormal submaximal cardiopulmonary exercise parameters predict impaired peak exercise performance in sickle cell anemia patients.

Authors:  Adam W Powell; Tarek Alsaied; Omar Niss; Robert J Fleck; Punam Malik; Charles T Quinn; Wayne A Mays; Michael D Taylor; Clifford Chin
Journal:  Pediatr Blood Cancer       Date:  2019-03-07       Impact factor: 3.167

2.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

3.  Probenecid Improves Cardiac Function in Subjects with a Fontan Circulation and Augments Cardiomyocyte Calcium Homeostasis.

Authors:  Jack Rubinstein; Jessica G Woo; Anastacia M Garcia; Tarek Alsaied; Jia Li; Per Kristian Lunde; Ryan A Moore; Martin Laasmaa; Amanda Sammons; Wayne A Mays; Shelley D Miyamoto; William E Louch; Gruschen R Veldtman
Journal:  Pediatr Cardiol       Date:  2020-08-07       Impact factor: 1.655

Review 4.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

Review 5.  Safety of maximal cardiopulmonary exercise testing in individuals with sickle cell disease: a systematic review.

Authors:  Kellsey N Smith; Tracy Baynard; Peter S Fischbach; Jane S Hankins; Lewis L Hsu; Peggy M Murphy; Kiri K Ness; Shlomit Radom-Aizik; Amy Tang; Robert I Liem
Journal:  Br J Sports Med       Date:  2021-07-20       Impact factor: 18.473

6.  Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.

Authors:  Aafke E Gaartman; Ajab K Sayedi; Jorn J Gerritsma; Tim R de Back; Charlotte F van Tuijn; Man Wai Tang; Harriët Heijboer; Koen de Heer; Bart J Biemond; Erfan Nur
Journal:  Br J Haematol       Date:  2021-07-15       Impact factor: 6.998

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.